Advances in diabetes-1 treatment by cell technology

https://bio.nikkeibp.co.jp/atcl/report/16/082400016/100500253/ The group around Tetsuya Ikemoto, a GI surgeon at the University Hospital of Fukushima,┬áprepares for an investigator-initiated clinical trial on insulin-producing cells (IPC) derived from autologous fat cells of human patients. He has finished safety evaluation and proof-of-concept experiments using diabetic mice and pigs. The insulin-producing cells under study are adipose-derived stem cells taken […]

Scroll to top